Learn More
About Orchestra
Orchestra Life Sciences is a technical consultancy. We provide strategic support and scientific expertise to advance pharmaceutical therapies for cancer and rare disease. Orchestra offers services instrumental to clients in nuclear medicine, radiation oncology, cell and gene therapies, regenerative medicines, and biotechnology. We work in concert with our clients to provide unparalleled expertise; speeding time to market.

Align
Our team of experts help clients align business strategies, regulatory approaches, engineering processes, and go-to-market plans.
Accelerate
We accelerate projects by streamlining supply chains, facilitating business relationships, and guiding regulatory compliance.
Achieve
We provide the right expertise at the right time to execute challenging projects, enable effective decision-making, and solve complex technical problems to achieve client goals.
Discover
Our Services
Orchestra’s team of consultants provide end-to-end expertise and support to bring commercial therapies to market
Find Out

Subject matter experts with more than 100 years of combined experience in novel therapies
Deep market knowledge and intelligence
Strategic relationships with key service providers, vendors, and suppliers
Proven track record of successful project execution
Radiopharmaceutical subject matter experts in nuclear
regulations, radiochemistry, process development, engineering, operations
Cell and gene therapy expertise in FDA regulations, process and analytical development, engineering, automation, and operations

Subject matter experts with more than 100 years of combined experience in novel therapies
Deep market knowledge and intelligence
Strategic relationships with key service providers, vendors, and suppliers
Radiopharmaceutical subject matter experts in nuclear
regulations, radiochemistry, process development, engineering, operations
Cell and gene therapy expertise in FDA regulations, process and analytical development, engineering, automation, and operations

Learn More
OUR CLIENTS
Orchestra serves clients on multiple continents in the disciplines of:
- Cell and Gene Therapy
- Biotechnology
- Radioligand Therapy
- Nuclear Medicine
- Radiation Oncology
- Fusion
Meet Our
Executive Management

Sumit Verma
Co-Founder & Partner

Emilie Pelletier
Co-Founder & CEO

Castor Armesto
Advisor
Meet Our
Our Team

Becky Cooper
Director of Quality Assurance and Compliance

Ernie Banks
Senior Program Manager & OPEX Leader
Strategic Project Director

Sandra Boyd
Senior Quality Director

Clement Cheung
Senior Consultant, Process Chemistry

Dale Simpson
Senior Advisor

Greg Bushman
Senior Consultant, Radiopharmaceutical Manufacturing

Mike Held
Project Manager

Lakeisha Green
Project Manager

Robert Matteoni
Project Manager

Ralph Butler
Senior Advisor

Sterling Marshall
Quality Engineer and Instrumentation

Valia Barreras
Director, Radiopharmacy Projects

John schmitz
Senior Project Director

Sam Meer
Vice-President Strategy and Supply chain

Michael Blackton
QA Executive

Kim Prefontaine
Executive Administrative Assistant

Timo Henk
Senior Engineer
Be Up To Date

Quality Infrastructure: The Framework for Success in Radiopharma
Quality infrastructure is an essential foundation for success in radiopharmaceutical and cell & gene therapy manufacturing. To meet modern industry expectations, companies must transition away

Identifying & Addressing Supply Chain Hurdles in Radiopharma
Radiopharmaceuticals Are Changing the Game Radiopharmaceuticals are at the forefront of modern medicine and are changing the way we fight complex cancers. These novel compounds

Designing Facilities for the Future of Autologous Cell Therapy: Top 5 Considerations
The innovative treatments of today demand complex and carefully considered manufacturing facilities. An autologous cell therapy manufacturing facility must ensure patient safety, product integrity, and

BioCentriq Partners with Orchestra Life Sciences to Advance Princeton, NJ Cell TherapyFacility Development
Princeton, NJ, January 14– BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic partnership with Orchestra Life Sciences (OLS),

Orchestra Life Sciences Partners with Life Couriers to Expand Supply Chain Capabilities and Broaden Access to Critical Cancer Treatments
Collaboration aims to enhance logistics solutions for advanced therapies and radiopharmaceuticals, ensuring timely delivery and expanding patient access St. Louis, Missouri — September 18, 2024

Orchestra Life Sciences Expands Access to Radioisotope Lead-212 (Pb-212) Through Strategic Collaboration with Precirix
This partnership aims to improve the delivery of targeted therapies for cancer patients by expanding access to the innovative Pb-212 radioisotope Brussels, Belgium and St.
Feel Free To